Skip to content
Research Article Open access CC BY 4.0

P53 Codon 72 Polymorphism and the Risk of Cervical Cancer in Zimbabwean Women

Vinie Kouamou, Nyasha Chin’ombe, Alice Matimba, Webster Kadzatsa, George Nyandoro, Cuthbert Musarurwa

International Journal of TROPICAL DISEASE & Health · pp. 1–6 · Published 30 Mar 2016

10.9734/IJTDH/2016/24676

Abstract

Aims: To investigate the prevalence of p53 codon 72 polymorphism in Zimbabwean women and risk of cervical cancer Study Design: Case-control study Place and Duration of Study: Parirenyatwa Referral Hospital in Harare in between January and December 2014. Methodology: Genomic DNA from cervical cancer patients and women without cancer was extracted from whole blood and genotyping of the p53 codon 72 polymorphism was performed using the polymerase chain reaction followed by restriction fragment length polymorphism method. Results: The frequencies of the Arg/Arg; Arg/Pro and Pro/Pro genotypes in cervical cancer patients were reported as 15.07%, 43.84% and 41.10% respectively. An unconditional logistic regression model was used to calculate odds ratios (ORs) with a corresponding 95% confidence interval [95%CI] as measure of risk and association between the p53 polymorphism and the development of cervical cancer. The p53 Arg/Arg was found to be at increased risk for the development of cervical cancer (OR= 1.78). However its association with the development of cervical cancer was not statistically significant (p-value= 0.29; 95% CI, 0.54-6.12). Conclusion: The prevalence of the Arg/Arg genotype in our study was low in women with cervical cancer. The genotype was poorly associated with the disease.

p53 codon 72 polymorphism cervical cancer Zimbabwe

References (17)

  1. 1 Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 [DOI]
  2. 2 Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer [DOI]
  3. 3 Epidemiology and prevention of human papillomavirus and cervical cancer in sub‐Saharan Africa: a comprehensive review [DOI]
  4. 4 TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies [DOI]
  5. 5 p53 Codon 72 Polymorphism and Cervical Neoplasia [DOI]
  6. 6 Cervical Cancer: Screening and Therapeutic Perspectives [DOI]
  7. 7 Polymorphism p53 codon‐72 and invasive cervical cancer: a meta‐analysis [DOI]
  8. 8 Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations [DOI]
  9. 9 Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women [DOI]
  10. 10 Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe [DOI]
  11. 11 p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women [DOI]
  12. 12 Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women [DOI]
  13. 13 The p53 codon 72 polymorphism in black South African women and the risk of cervical cancer [DOI]
  14. 14 The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women [DOI]
  15. 15 p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation [DOI]
  16. 16 TP53 codon 72 polymorphism and risk for cervical cancer in Portugal [DOI]
  17. 17 TP53 codon 72 polymorphism does not affect risk of cervical cancer in patients from The Gambia [DOI]

Cited by 14

Association between the p53 polymorphisms and cervical cancer risk: an updated meta-analysis

Xi-Qin Zhang, Xiao-Hui Bai, Hui-Zhen Zhang · Frontiers in Oncology · 2025

Genetic Susceptibility for Cervical Cancer in African Populations: What Are the Host Genetic Drivers?

Oppah Kuguyo, Nomsa Tsikai, Nicholas E. Thomford · OMICS: A Journal of Integrative Biology · 2018

Association of TP53 rs1042522 with cervical cancer in the sub‐Saharan African population: a meta‐analysis

Abram Bunya Kamiza, Steve Kamiza, Mwiza Gideon Singini · Tropical Medicine & International Health · 2020

A cervical cancer biorepository for pharmacogenomics research in Zimbabwe

Oppah Kuguyo, Nyasha Chambwe, Charles F. B. Nhachi · BMC Cancer · 2022

Codon 72 Polymorphism of TP53 Gene in Cervical Biopsies with Abnormal Histology in Bushehr Province

Marzeah Zaker Hosseini, Department of Genetics, Colleague of Science, Kazerun branch, Islamic Azad University, Kazerun, Iran, Sirous Naeimi · Iranian South Medical Journal · 2018

Showing 6 of 14 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

16

Page views

0

PDF downloads

2

Outbound clicks

14

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.